Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ozone (O3) is a triatomic form of oxygen used in medical therapy for its potent anti-inflammatory, analgesic, and immunomodulatory properties. In the context of carpal tunnel syndrome (CTS), medical ozone is typically administered via ultrasound-guided perineural injection into the space surrounding the median nerve. The mechanism of action involves the modulation of oxidative stress, inhibition of pro-inflammatory cytokines (such as TNF-alpha and IL-1beta), and enhancement of local microcirculation. This specific application is being investigated by Yunus Burak Bayır in a randomized, triple-blind clinical trial comparing the effectiveness of ozone injections against corticosteroids and 5% dextrose for the management of moderate CTS symptoms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ozone (Premier Research Laboratories).